# Symbiotics and Systemic Inflammation in Chronic Kidney Disease

> **NCT04769687** · PHASE2 · UNKNOWN · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 62 (estimated)

## Conditions studied

- Chronic Renal Failure
- Diabete Type 2
- Systemic Inflammation

## Interventions

- **BIOLOGICAL:** probiotic Vivomixx®
- **BIOLOGICAL:** prebiotic Orafti®Synergy1
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04769687
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-21
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-11-01
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04769687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04769687, "Symbiotics and Systemic Inflammation in Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04769687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*